Bain Capital Life Sciences Fund II, L.P. 13D and 13G filings for Atea Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-24 5:15 pm Sale |
2021-09-22 | 13D | Atea Pharmaceuticals, Inc. AVIR |
Bain Capital Life Sciences Fund II, L.P. | 3,178,532 3.800% |
-846,856 (-21.04%) |
Filing |
| 2021-09-03 5:00 pm Sale |
2021-09-01 | 13D | Atea Pharmaceuticals, Inc. AVIR |
Bain Capital Life Sciences Fund II, L.P. | 4,025,388 4.900% |
-757,714 (-15.84%) |
Filing |
| 2020-11-12 4:15 pm Purchase |
2020-11-03 | 13D | Atea Pharmaceuticals, Inc. AVIR |
Bain Capital Life Sciences Fund II, L.P. | 4,783,102 5.800% |
4,783,102 (New Position) |
Filing |